Opens in a new tab

Historical Virgin Fiber Folding Boxboard Manufacturer

Country
FranceFrance
Listing ID
L#20251045
Target Price
€125,000,000
Revenue
€71,500,000
EBITDA
TBA

Description

This company stands as a leading, long-established European producer of high-quality Virgin Fiber Folding Boxboard (FBB), a specialization that underpins its focus on producing premium packaging solutions for sensitive markets such as pharmaceuticals, food and beverage, and cosmetics. Its core product, known specifically as VC – Folding Boxboard, leverages the superior characteristics of virgin fibers to ensure the quality, purity, and strength required by its discerning and well-diversified customer base across Europe.

The facility is an integrated paper mill with a large operational footprint:

  1. 01
    Total Facility Area150,000m2
  2. 02
    Total Production Capacity170,000 tons/year.
  3. 03
    Net Sellable Production148,000 tons.

Production Metrics

  1. 01
    Pulp InputUtilizes a mix of 75% Mechanical Pulp and 25% Chemical Pulp.
  2. 02
    Key EquipmentOperates two cardboard machines (PM2 and PM3), one rewinder, and four sheeters.
  3. 03
    Capacity DistributionThe higher-capacity machine (PM3) accounts for 110,000 tons/year capacity, while PM2 contributes 60,000 tons/year.

The company serves critical end-markets across Europe:

  1. 01
    End-MarketsStrong presence in Pharmaceutical, Food & Beverage, and Cosmetics packaging.
  2. 02
    Customer BaseHighly diversified, serving 250+ clients

Basic Details

Listing ID
L#20251045
Country
France
Industry
Manufacturing
Deal Status
Available
Target Price
€125,000,000
Revenue
€71,500,000
EBITDA
TBA
Revenue Multiple
1.75x
EBITDA Multiple
TBD

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000